NCT07478341 Hybrid Breastfeeding Education in Late Pregnancy: Effects on Antenatal Attachment and Breastfeeding
| NCT ID | NCT07478341 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Emel GÜÇLÜ CİHAN |
| Condition | Breast Feeding |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2025-12-30 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2025-12-30 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled study aims to examine the effect of individualized hybrid breastfeeding education provided during late pregnancy on antenatal attachment and breastfeeding behaviors among first-time mothers. Participants will be randomly assigned to either the intervention or control group. Women in the intervention group will receive individualized hybrid breastfeeding education beginning at the 36th week of pregnancy. The program includes a face-to-face individual breastfeeding education session at 36 weeks of pregnancy and a reinforcement and practice session at 38 weeks. Participants will also have access to personalized digital educational materials, short educational videos, and online consultation support. In the postpartum period, participants will receive an online support session during the first week after birth and a follow-up session through online communication or telephone at the sixth postpartum week. The control group will receive routine hospital education during pregnancy. After completion of the study, the same educational materials will be provided to the control group in accordance with ethical principles. Data will be collected using the Demographic Information Form, Breastfeeding Behavior Evaluation Form, Antenatal Attachment Inventory, and Breastfeeding Self-Efficacy Scale. Written informed consent will be obtained from all participants prior to enrollment.
Eligibility Criteria
Inclusion Criteria: Aged 18-35 years, At 36 weeks of gestation or later, Experiencing their first pregnancy (primiparous), Having a singleton pregnancy, Able to read and write in Turkish and capable of communication, Having access to a smartphone or the internet, Free from any physical or mental health problems that would prevent participation in the education, Willing to voluntarily participate in the study and provide written informed consent. Exclusion Criteria: Presence of chronic physical illness or pregnancy complications (e.g., preeclampsia, gestational diabetes), Multiple pregnancy, Gestation earlier than 36 weeks, Inability to actively participate in the education due to communication barriers or cognitive impairment, Lack of access to a smartphone or the internet, Failure to attend any stage of the educational program or voluntary withdrawal from the study, Refusal to participate in the study or failure to sign the informed consent form.
Contact & Investigator
Asst. Prof.
PRINCIPAL INVESTIGATOR
Kahramanmaras Sutcu Imam University
Frequently Asked Questions
Who can join the NCT07478341 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 35 Years, studying Breast Feeding. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07478341 currently recruiting?
Yes, NCT07478341 is actively recruiting participants. Contact the research team at emel_guclu4606@hotmail.com for enrollment information.
Where is the NCT07478341 trial being conducted?
This trial is being conducted at Elbistan, Turkey (Türkiye).
Who is sponsoring the NCT07478341 clinical trial?
NCT07478341 is sponsored by Emel GÜÇLÜ CİHAN. The principal investigator is Asst. Prof. at Kahramanmaras Sutcu Imam University. The trial plans to enroll 64 participants.